Community Acquisition of ESBL-Producing E. coli

Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is resistant to most β-lactam antibiotics except carbapenems. The genes encoding ESBLs are located mainly on transferable plasmids — often in association with other antibiotic-resistance genes. ESBL-producing E. coli infections have generally been healthcare associated, but acquisition in the community has been reported in multiple countries since the mid-2000s. These …

[1]  B. Foxman.  Editorial commentary: extended-spectrum β-lactamase-producing escherichia coli in the united states: time to rethink empirical treatment for suspected E. coli infections? , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Richter,et al.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.